Strength Training to Improve Gait in People With Multiple Sclerosis
Targeted Strength Training to Improve Gait in People With Multiple Sclerosis: a Feasibility Study
1 other identifier
interventional
11
1 country
1
Brief Summary
This study will pilot a strengthening intervention targeted to muscles found to be important to gait in people with multiple sclerosis (MS). Previous studies that have tried to strengthen leg and trunk muscles in people with MS have failed to improve walking ability consistently. The investigators think that is because strengthening exercises were not targeted to the correct muscle groups. For this study the investigators propose targeting muscle groups that they have found to be strong contributors to walking in a prior study. This is the first study to target these muscles, so the investigators propose doing a small trial to first evaluate the feasibility of the strength program and the outcomes. The investigators will measure strength and walking measures twice before and once after an 8-week strengthening intervention in a single group of 10 people with MS who are able to walk independently. The results of this study will help inform future, larger trials that could change the way strength training is conducted in people with MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable multiple-sclerosis
Started May 2017
Shorter than P25 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2017
CompletedStudy Start
First participant enrolled
May 23, 2017
CompletedFirst Posted
Study publicly available on registry
June 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 8, 2017
CompletedApril 13, 2018
April 1, 2018
6 months
May 23, 2017
April 11, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Muscle Strength
Muscle strength measured by hand-held dynamometry (HHD) and clinical strength tests
Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up)
Change in Timed 25 Foot Walk (T25FW)
Gait speed over a 25 foot distance
Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up)
Secondary Outcomes (4)
Change in 6-Minute Walk Test
Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up)
Change in Dynamic Gait Index
Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up)
Change in Multiple Sclerosis Walking Scale-12
Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up)
Change in Patient Specific Functional Scale
Week 0 (Baseline 1); Week 10 (Follow-Up)
Study Arms (1)
Strength training
EXPERIMENTALStrength exercises for ankle PF, hip abduction, and trunk muscles. Exercises will be done in three standard positions of supine, sidelying, prone, seated, and standing. Exercises during the initial 4 weeks will be completed 2x week with supervision of a physical therapist and 2x week at home, for a total of 4x week. For the final 4 weeks of the intervention will be completed 1x week with supervision and 3x week at home.
Interventions
Eligibility Criteria
You may qualify if:
- People with MS,
- Age 18-65,
- A confirmed diagnosis of MS, and
- Are ambulatory for 100m without an assistive device (EDDS 0-5.5), and
- Have a gait speed measured by time to walk the 25-foot walk test of at least five seconds.
You may not qualify if:
- Subjects are not ambulatory,
- Subjects rely on a wheelchair,
- Subjects cannot ambulate 100m (EDDS 6 or greater) without use of assistive devices, braces, or orthotics,
- Walk the T25FW in less than five seconds,
- Have lower extremity spasticity of 2 or greater on the Modified Ashworth Scale (MAS),
- Have pain or other conditions that limit ambulation or ability to test muscle strength,
- Cannot give consent,
- Cannot follow simple directions,
- Have had an exacerbation in the past month,
- Have had changes to their drug therapy in the last month,
- Have other neurologic diagnoses, or
- Are currently undergoing physical therapy for strength training.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Denver
Aurora, Colorado, 80045, United States
Related Publications (1)
Manago MM, Hebert JR, Schenkman M. Psychometric Properties of a Clinical Strength Assessment Protocol in People with Multiple Sclerosis. Int J MS Care. 2017 Sep-Oct;19(5):253-262. doi: 10.7224/1537-2073.2016-078.
PMID: 29070966BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret Schenkman, PT, PhD
University of Colorado, Denver
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2017
First Posted
June 5, 2017
Study Start
May 23, 2017
Primary Completion
November 8, 2017
Study Completion
November 8, 2017
Last Updated
April 13, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share